首页 | 本学科首页   官方微博 | 高级检索  
     

胃癌血管靶向肽GX2 对胃癌血管内皮细胞靶向性的鉴定
引用本文:殷继鹏 窦维佳 李明 惠晓丽 胡皓 幺立萍 聂勇战 吴开春. 胃癌血管靶向肽GX2 对胃癌血管内皮细胞靶向性的鉴定[J]. 现代生物医学进展, 2012, 12(13): 2470-2473
作者姓名:殷继鹏 窦维佳 李明 惠晓丽 胡皓 幺立萍 聂勇战 吴开春
作者单位:1. 第四军医大学西京消化病医院肿瘤生物学国家重点实验室 陕西西安710032
2. 西安交通大学第一附属医院 陕西西安710061
基金项目:国家自然科学基金重大项目(81090270、81090273);国家自然科学基金项目(30873005);国家973项目(2010CB529302);国家科技重大专项新药创制(2009ZX09103-667,2009ZX09103-009-RC06)
摘    要:目的:证明胃癌血管靶向肽GX2能够与胃癌血管内皮细胞特异性结合,在体内对胃癌血管具有靶向性。方法:体外实验,合成GX2与FITC的复合物FITC-GX2,分离原代人脐静脉内皮细胞HUVEC,将HUVEC与人胃癌细胞系SGC7901共培养,建立共培养血管内皮细胞模型来模拟胃癌血管,利用免疫荧光的方法观察GX2与共培养内皮细胞Co-HUVEC的结合情况;体内实验,构建99mTc标记的GX2分子示踪探针,SPECT显像观察GX2的胃癌血管靶向性。结果:免疫荧光结果显示GX2能与Co-HUVEC特异性结合,而与人胃癌细胞SGC7901不结合;SPECT显像结果证明了GX2在荷瘤裸鼠体内能够浓集到肿瘤部位,具有良好的靶向性。结论:GX2能与胃癌血管内皮细胞特异性结合,且具有在体靶向到胃癌血管的能力;GX2具有胃癌诊断的潜在价值,并能应用于胃癌血管抑制治疗。

关 键 词:肿瘤靶向  GX2  胃癌  人脐静脉内皮细胞

Identification of Targeting Ability of GX2 Homing to Gastric CancerVasculature
YIN Ji-peng,DOU Wei-ji,LI Ming,HUI Xiao-li,HU Hao,YAO Li-ping,NIE Yong-zhan,WU Kai-chun. Identification of Targeting Ability of GX2 Homing to Gastric CancerVasculature[J]. Progress in Modern Biomedicine, 2012, 12(13): 2470-2473
Authors:YIN Ji-peng  DOU Wei-ji  LI Ming  HUI Xiao-li  HU Hao  YAO Li-ping  NIE Yong-zhan  WU Kai-chun
Affiliation:1(1 Xijing Hospital of Digestive Diseases & State Key Laboratory of Cancer Biology,Xi’an,710032,China; 2 First Affiliated Hospital,Xi’an Jiaotong University,Xi’an,710061,China)
Abstract:Objective: To identify targeting ability of GX2 homing to gastric cancer vasculature in vivo and in vitro.Methods: Hu-man umbilical vein endothelial cells(HUVEC) were isolated and cultured,and the tumor endothelial cell coculture model(Co-HUVEC) was prepared using HUVEC and the human gastric cancer cell line SGC7901 in Transwell plates.A FITC-GX2 complex were synthe-sized and used in immunofluorescence staining in vitro.Samples were examined using a fluorescence microscope and binding specificity to Co-HUVEC was evaluated.Besides,GX2 was labeled with the radioactive isotope 99mTc,and targeting efficacy was observed using SPECT imaging in the nude mice model bearing SGC7901 tumor xenografts.Results: Immunofluorescence staining demonstrated that GX2 bound specifically to Co-HUVEC but not to SGC7901 cells.SPECT imaging showed that GX2 targeted the tumor tissue.Conclusions: GX2 can bind specifically to Co-HUVEC and home to gastric cancer vasculature.GX2 can also be applied to diagnosis and therapy for tumor angiogenesis.
Keywords:Tumor targeting  GX2  Gastric cancer  HUVEC
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号